Viscosupplementation Market - Current status and future trends

Viscosupplementation is a minimally invasive procedure that involves injection of gel-like substances into a joint to assist the viscous properties of synovial fluid. As of now hyaluronate injections are only approved viscosupplementation treatment of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Hyaluronic acid is observed to be an integral component of the extracellular matrix as it contributes significantly to migration and cell proliferation. Hyaluronic acid acts as a joint lubricant and elastic in nature that allows it to act as a shock absorber because of its viscous nature. Chemical modification allows Hyaluronic acid to transform into several physical forms such as soft or stiff hydrogels, non-woven meshes, flexible sheets, viscoelastic solutions, electrospun fibers, macroporous, fibrillar sponges, and nanoparticulate fluids for use in a range of preclinical and clinical applications. According to the WHO, osteoarthritis is a degenerative joint disease that mainly affects the articular cartilage and is related with aging. This condition affects the joints that have been continually stressed over the years including the hips, fingers, lower spine and knees. According to the WHO, globally, around 9.6% men and 18.0% women are above the age of 60 years and suffer from symptomatic osteoarthritis, which is one of the top disabling diseases in developed countries. Osteoarthritis is mostly classified in two types: primary and secondary where primary osteoarthritis occurs due to aging and wear and tear of joints and secondary osteoarthritis occurs due to an accident or obesity at an early stage.

Factors driving the growth of viscosupplementation market are increasing geriatric population, increasing demand for minimally invasive surgical procedures, high patient awareness about new drugs and devices for the treatment of osteoarthritis and rising obese population globally. However, lack of safety and inefficiency of the products might hamper the market growth. The product innovation and process development is an opportunity window for market players as safety and efficacy are the major concerns of viscosupplementation products. Thus, introduction of products that helps to overcome these concerns have an opportunity to enter and establish in the global viscosupplementation market.

The FDA approved hyaluronates currently available in the viscosupplementation market are Hyalgan (Sanofi), Euflexxa (Ferring Pharmaceuticals, Inc.), Orthovisc (Anika Therapeutics), Supartz and Gel-One (Seikagaku Corporation), and Synvisc, Synvisc One (Genzyme) and Durolane (Q MED AB).

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10232

North America is the largest viscosupplementation market globally accounting for high product demand, high awareness in the region and acceptance of high priced products. Europe experienced an economic downturn that created problem in the hyaluronic acid products market as reimbursement policies turned out to be difficult but still the premium priced products were accepted in some of the countries. Although European market is expected to review and provide essential opportunity for viscosupplementation products as the economical conditions are reviving. Asia-Pacific and RoW observed to be the emerging markets for viscosupplementation and Asia-Pacific viscosupplementation market is especially driven by economic development, healthcare facility enhancements and high demand for minimally invasive surgeries.

Some of the key players of viscosupplementation market are Alcon, Inc., F. Hoffmann-La Roche Ltd., Allergan, Inc., Fidia Farmaceutici SpA, Anika Therapeutics, Inc., Ferring Pharmaceuticals, Inc., GALDERMA S.A., LifeCore Biomedical LLC, Hyaltech Ltd. and others.

Computed Tomography Market To See Good Times Ahead

Transparency Market Research has published a new market study on the global computed tomography (CT) market that delves into developments in the said market from 2011 to 2017. According to the report’s findings, the market will display a CAGR of 4.5% between 2011 and 2017, resulting in the market’s valuation increasing from US$4.3 bn in 2011 to US$5.6 bn by 2017. The report is titled “Computed Tomography (CT) Market: Global Industry Analysis, Size, Share & Forecast (2010 - 2017)” and is available for sale on the company’s website.

The report looks into developments in the market from the perspectives of market indicators, the latest trends, growth opportunities, and competitive hierarchy across North America, Asia Pacific, Europe, and Rest of the World for the 2011-2017 period. The report is prepared using standard research methodologies and validated analytical tools such as Porter’s five forces analysis and SWOT analysis to ascertain an accurate trajectory of the market’s growth during the forecast period.

Computed tomography is a diagnostic imaging tool that produces detailed pictures of internal organs, soft tissues, bones, and blood vessels. It uses special X-ray equipment to create cross-sectional images of distinct areas of scanned objects, which can be reformatted in two-dimensional or even three-dimensional planes.

The report cites several reasons for the growth of the global CT market. An increasing pool of the ageing population and an increasing patient pool with chronic diseases are the foremost reasons for growth of the CT market. In particular, Asia Pacific is exhibiting a rise in its geriatric population, thereby displaying an increasing demand for modern diagnostics.

The report segments the global CT market on the basis of two criteria, namely product type and region. According to product type, the segments of this market are low-end slice CT, high-end slice CT, and mid-end slice CT. Amongst all, high-end slice CT is expected to gather a major chunk of the revenue, estimated at about 55.9% by the end of 2017. In absolute numbers, this equals US$3.1 bn.

Geographically, North America is currently the leading market for CT. The region being traditionally technologically advanced and home to a significant health-conscious aging population are the reasons for this. However, during the forecast period, Asia Pacific is expected to exhibit the fastest growth in comparison to other regional markets for computed tomography. This is due to the rising awareness among individuals about modern diagnostics, improved financial state, and the emergence of modern healthcare facilities in this region.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=227

In other developing regions, increasing disposable incomes and increasing awareness about the importance of timely diagnosis of chronic diseases are the major factors driving the computed tomography market. These factors are further augmented by the declining cost of equipment and increasing accuracy due to consistent technological advancements in the CT industry.

The report mentions and profiles top players in the global computed tomography market, which are GE, Toshiba, Siemens, and Phillips. These companies have been profiled for attributes of product portfolio and specification, financial standing, business positioning, and SWOTs.

Forensic Technologies Market - An Overview of Growth Factors

As technology penetrates practically all walks of life, it is no surprise that solving crimes is driven by modern technologies and methods. Today scientists use retinal scanning, DNA tests, mass spectrometry, high-performance liquid chromatography, and other advanced technologies to reconstruct crimes and accidents. In the entire operative, right from the collection of evidence at crime site to presentation of investigated results in courts of law, forensic technology has dramatically improved the quality and precision of criminal investigations.

Of the several investigating methodologies, DNA profiling is extensively used and is expected to rise at a CAGR of 11% for the 2013-2019 period. DNA profiling is significant for crime investigations that are otherwise impossible to crack due to insufficient non-DNA-based evidence. Currently, DNA profiling is rising in demand rapidly, as law enforcement agencies are considerably dependent on this for criminal investigation.

Standardization of Processes to Lower Forensic Technologies Market Value in North America and Europe

Transparency Market Research states that the global forensic technologies market will expand at a CAGR of 12.4% between 2013 and 2019. This will result in the market’s valuation reaching US$17.7 bn by 2019, increasing from US$8.3 bn in 2012.

In terms of geography, North America and Europe are the leading markets for forensic technologies. In 2012, the global market was dominated by North America, which was closely followed by Europe, which resulted in the two regions accounting the majority share in the global market. This is because forensic technologies such as biometrics/fingerprints, DNA profiling, and firearms identification are a standard part of the criminal investigation procedure in these regions and are carried out through automated systems. Further standardization of processes will result in reduced expenditure on end-to-end crime analysis and a decline in the value of forensic services in these regions.

Adoption of Technology-based Criminal Investigation Rising in Asia Pacific, RoW Forensic Technologies Markets

Download PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=819
By the end of 2019, Asia Pacific and Rest of the World are expected to collectively hold a share of close to 60% in the global market. In these regions, several countries have initiated DNA database programs on a mass scale to be prepared for future eventualities. For instance, the Dubai police is investing heavily on building forensic technologies/services infrastructure and for purchasing hi-tech forensic equipment and supplies. Thus, the Middle East market will render attractive growth opportunities for forensic equipment providers. A multitude of other favorable factors will propel the growth of the forensic technologies/services market in these regions; hence, Asia Pacific and Rest of the World will garner a significant share in the global forensic technologies market going forward.

Top players that are involved in forensic technologies market globally are NMS Labs Inc., Spex Forensics, GE Healthcare Life Sciences, Pyramidal Technologies Ltd., LGC Forensics, and Eurofins Medigenomix GmbH.

Medical Waste Management Industry Offering High-growth Opportunities for Market Players

In response to the expanding healthcare industry, the amount of medical waste generated around the world has also substantially increased, thus making global medical waste management market imperative for any society. The report, titled “Medical Waste Management Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” published by Transparency Market Research aims to provide a granular analysis of the evolution of the market and the key factors impacting its growth trajectory.

Medical waste refers to the waste generated in healthcare institutions such as hospitals, physician’s offices, clinics, dental hospitals, veterinary clinics or hospitals, blood banks, and medical research institutes, laboratories, or facilities. This waste may include solid waste that is generated during diagnosis, treatment, or immunization of human beings or animals, during the testing or production of biologics or any research pertaining thereto. The definition of medical waste is therefore not limited to blood soaked bandages, discarded surgical instruments, or culture dishes and other glassware.

The global market for medical waste management stood at US$14.5 bn in 2012. Rising at a CAGR of 4.8% between 2013 and 2019, the market is expected to reach US$20.1 bn by the end of 2019.

The waste generated from medical institutes can be categorized into four major segments, vis-à-vis general waste, infectious, hazardous, and radioactive. “Approximately 80% of the medical waste generated every year consists of papers, plastics, and other materials that very similar to the waste generated in households or offices,” said a lead TMR analyst. He also added that the remaining 20% to 25% of the waste generated comprises bioactive waste such as cultures, used syringes, stocks, blood-soaked bandages, expired medicines, and others, which are equally hazardous to the environment and human health alike.

For the purpose of the study, the market for medical waste management has been segmented into collection, processing, and disposal based on activity. Of these, the collection segment accounted for the maximum share in the market in 2012, followed by the disposal and processing segments. In terms of the overall quantity of medical waste generated, the report bifurcates the market into large quantity generators (LQGs) and small quantity generators (SQGs). Of these, LQGs held the largest share in the market in 2012. However, the report projects the SQGs segment to exhibit a higher CAGR over the forecast period.

Download Brochure of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2268

Regionally, North America held the largest share in the global medical waste management market, trailed by Europe. Both these regions are anticipated to retain their position in the market through the report’s forecast period. Favorable government regulations mandating efficient disposal of medical waste will drive the market for medical waste management in North America and Europe. In Asia Pacific, countries such as New Zealand, Australia, and Japan exhibit the most lucrative prospects for the waste management market. However, emerging economies such as India and China are yet to be tapped by medical waste management players to their complete potential due to the lack of awareness about medical waste management services and the absence of proper government regulations supporting the spread of the market. In the Rest of the World region, South Africa, Israel, Turkey, Mexico, and the UAE have emerged as the most lucrative markets for medical waste management.

To study the prevailing competition, the report also profiles some of the most prominent companies operating in the market, such as Republic Services, Inc., Waste Management, Inc., Stericycle, Inc., Clean Harbors, Inc., Suez Environment SA, Veolia Environmental Services, and US Ecology, Inc.

Hematology Diagnostics Market to See Good Times Ahead

In a report, titled “Hematology Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” Transparency Market Research presents a comprehensive overview of the factors impacting the growth trajectory of the global market for hematology diagnostics between 2015 and 2023.

Hematology is a branch of medicine dealing with the diagnosis, treatment, and prevention of ailments related to the bone marrow, blood, immunology, the vascular system, and hemostasis (blood clotting). Hematological tests are carried out to diagnose various blood-related diseases such as anemia, leukemia, blood cancer, and autoimmune disorders, among others. The method encompasses various in vitro diagnostic (IVD) techniques such as hemostasis, molecular diagnostics, blood analysis, flow cytometry, and immunodiagnostics, which help in measuring various parameters of blood with improved precision at a comparatively lower cost.

The increasing incidence of blood-related disorders has been a key factor driving the global market for hematology diagnostics. As per data released by the Leukemia & Lymphoma Society (LLS), in the U.S. alone, approximately 1.6 million new cases of cancer were reported in 2015. About 9.8% of this demographic were diagnosed with leukemia, lymphoma, and myeloma. Additionally, as per the findings of the National Hemophilia Foundation, approximately 400,000 cases of people suffering from hemophilia are registered globally. With the population of people aged above 65 years being projected to reach over 83.7 million by 2050, as per the Administration for Community Living, which is twice that estimated in 2012, the market for hematology diagnostics is anticipated to exponentially grow in the near future.

Get Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8848

It is therefore extremely important for vendors operating in the market for hematology diagnostics to be well aware of the market’s present dynamics and how various factors will shape its future. The information comprised in the report is aimed at assisting the market stakeholders with insights pertaining to the prevailing trends and projected factors that may influence the market’s growth trajectory over the forecast period.

Providing in-depth information pertaining to the technological developments and government policies supporting the further development of healthcare infrastructure across the most lucrative regions, the report makes for a resourceful guidebook for those seeking pertinent information about the hematology diagnostics market.

The report broadly classifies the global hematology diagnostics market on the basis of end user, product, and geography. By product, the market is bifurcated into hematology reagents and hematology analyzers. Based on end user, the market is segmented into clinical laboratories, hospitals, research institutes, and academics institutes.

Regionally, the global hematology diagnostics market constitutes Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. Of these, North America presently dominates the global hematology diagnostics market. However, the market in Asia Pacific is expected to exhibit the highest CAGR during the forecast period.

To provide a holistic overview of the prevailing competitive scenario of the market for hematology diagnostics, the report profiles some of the most prominent vendors operating in the market, such as HemoCue AB, Beckman Coulter, Sysmex, Abbott Laboratories, Mindray Medical HORIBA, Ltd., International Limited., Roche Diagnostics A/S, Siemens AG, and Bio-Rad Laboratories, Inc.

Cardiovascular Monitoring and Diagnostic Devices Market to Grow due to Rising Incidence of Cardiovascular Diseases

Cardiovascular diseases have been the leading cause of death worldwide and will be the leading cause till 2030, according to World Health Organization (WHO). The major factors which increases the burden of this disease are lifestyle habits such as physical inactivity, smoking and unhealthy diet. These factors which result in obesity and hypertension are also identified as the underlying cause of cardiovascular disorders. The number of people diagnosed with coronary artery disease, peripheral artery disease, pulmonary embolism and congenital heart disease is rising rapidly worldwide. Therefore, the need for preventive healthcare has arisen and realized by countries with high burden of these disorders. Thus, the demand for cardiovascular monitoring and diagnostic devices is expected to rise in such countries.

Aging is one of the major factors driving the demand for cardiovascular monitoring and diagnostic devices. As the aging process advents, the risk of hypertension, weakening of heart muscles, obesity and diabetes grows, thus increasing the risk of cardiovascular diseases. Moreover, advent of new technologies enabling portability in handling and performing the test will drive the global cardiovascular monitoring and diagnostic devices market further. For example, technologies such as implantable loop recorders and wearable heart rate monitors would compel other players in the market to pace up with their product technologies, which will fuel the market growth.

Based on the product type, the global cardiovascular monitoring and diagnostic devices market is categorized into six segments namely ECG systems, cardiovascular diagnostic catheters, holter monitors, event monitors, implantable loop recorders and ECG management systems. Among these, ECG systems held the majority share of the global cardiovascular monitoring and diagnostic devices market in 2012, while the global market for implantable loop recorders is expected to grow at a faster pace during the forecast period. The ECG systems market is majorly dominated by the resting ECG systems owing to higher demand from customers due to convenience in the procedure. The demand for these systems will rise further owing to their lower price and rising demand from patients. Also, it is more convenient to be used among elderly patients and patients at high risk of congestive heart failure.

Get a Sample for this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2385

Geographically, the global cardiovascular monitoring and diagnostic devices market is categorized into four regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America dominated the global cardiovascular monitoring and diagnostic devices market in 2012 due to high patient awareness coupled with the presence of sophisticated healthcare infrastructure. Also, the adoption of new technologies is rapid in this region which results in high demand for advanced cardiovascular monitoring and diagnostic devices. Conversely, the Asia-Pacific region is expected to grow at a higher CAGR, owing to the high presence of unmet healthcare needs, high patient population and increasing healthcare expenditure.

The global cardiovascular monitoring and diagnostic devices market is characterized by the presence of few big players such as GE Healthcare, Philips Healthcare, Boston Scientific Corporation, Siemens Healthcare, Nihon Kohden Corporation, St. Jude Medical, Inc. and Welch Allyn, Inc. Competition is high among these players which compels them to seek for new technologies and devices providing accurate and convenient testing.

Peripheral Vascular Devices Market: 2012 World Market Outlook and Forecast up to 2018

Peripheral vascular disease (PVD) is narrowing of arteries outside the brain and heart. Risk factors for the growth of PVD include hypertension, obesity, diabetes and smoking. More than 5% of the population above the age of 50 years suffers from PVD. Insufficient blood flow and narrowing of arteries are the most common peripheral diseases caused due to plaque buildup. The global market for peripheral vascular devices was valued at USD 4,802.6 million in 2011, with an expected CAGR of 7.1% from 2012 to 2018. The North American region accounts for the largest market share. Asia-Pacific is the fastest growing market, on account of favorable demographic and economic conditions.

The major segments in the market include peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices and inferior vena cava filters. Embolic protection devices are the fastest growing segment in the total peripheral vascular devices market.

Growth of the global peripheral vascular devices market is fuelled by the rate of population growth globally and the high incidence of peripheral vascular diseases due to increasing aging population. Rising healthcare awareness and increasing disposable incomes are other important factors driving the growth of the market.

Key players such as Abbott Laboratories, Cordis Corporation and Boston Scientific Corporation dominate the market with their global presence. With the increasing aging population in developed economies such as North America and Europe, the demand for peripheral vascular devices would also increase. Asia-Pacific will record a high CAGR, due to the continuous increase in population as well as disposable incomes. Economic growth and technological advancements are primary factors stimulating the growth of peripheral vascular devices market in Asia-Pacific region. Global Peripheral Vascular Devices Market, by Product Types, 2011 (USD Million)

Increasing Awareness and Affluence among Consumers Driving Peripheral Vascular Devices Market

Peripheral vascular disease (PVD) is the narrowing of arteries outside the heart that carry blood to the limbs, the all-important cerebral region, and other internal organs. The main risk factors fueling the growth of the peripheral vascular devices market are obesity, smoking, hypertension, and diabetes. Studies state that more than 5% of the global population above 50 years suffers from PVD. The market for peripheral vascular devices is fueled by the increasing awareness about the disease, rising preference for minimally invasive surgeries, and rising disposable incomes allowing patients to go for more advanced medical procedures.

Peripheral vascular disease is highly correlated with the changing modern lifestyle, addictions, and unhealthy eating habits. People consuming tobacco products, alcohol, and cigarettes are expected to experience cardiac arrest, blood clotting or other vascular diseases at some point in time. Such factors also contribute to the growing peripheral vascular devices market in the world. The global market for peripheral vascular devices is expected to expand due to the number of diagnostic and therapeutic interventions for PVD management across various healthcare platforms.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=472

Steady Growth Expected for All Product Segments of Peripheral Vascular Devices Market

The PVD market typically includes angiography catheters, IVC filters, hemodynamic flow alteration, plague modification devices, and EVAR stent grafts as the main devices used for treating peripheral arterial conditions. These devices are highly effective and efficient. They are used to decrease the inconvenience experienced by patients during the surgical procedure.

However, the major product segments that have grown impressively in the past few years and contributed to the overall growth in the market are PTA guidewires, atherectomy devices, eripheral vascular stents, chronic total occlusion devices, peripheral transluminal angioplasty balloon catheters, aortic stents, inferior vena cava filters, synthetic surgical grafts, and embolic protection devices.

Of all these products, the market for embolic protection devices is the fastest growing product segment in the global PVD market. Growth in the market for stents is also accelerating as these medical devices are commonly used for treating various problems related to coronary arteries.

All these segments are anticipated to witness continuous growth and demand from various regions in the next four years.